Division of Isotope Application, Institute of Nuclear Energy Research, Taoyuan County-32546, Taiwan (R.O.C.).
Nucl Med Biol. 2011 May;38(4):605-12. doi: 10.1016/j.nucmedbio.2010.10.008. Epub 2010 Dec 28.
(18)F-labeled sodium fluoride ([(18)F]NaF) is a useful bone imaging agent that has been demonstrated to be significantly more accurate than (99m)Tc-labeled methylene diphosphonate for the detection of both sclerotic and lytic lesions in various malignancies. A reliable anion-exchange HPLC method equipped with suppressed conductivity and radioactive detectors has been developed in order to analyze the content of NaF and radiochemical purity in [(18)F]NaF radiopharmaceuticals. The method described for fluoride analysis uses an isocratic elution of NaF in a Hamilton anion-exchange column using a mobile phase that consists of 7.5 mM sodium carbonate and 0.018 mM potassium thiocyanate. The flow rate was 1.0 ml/min. The method was validated in accordance with several parameters, including system suitability, specificity, precision, accuracy, linearity, robustness, limit of detection and limit of quantification. The results are described as follows: (1) The system suitability includes the tailing factor, theoretical plate number and resolution, which are 1.192534, 2729.6594 and 16.7415, respectively. (2) For specificity, the solvent peak and chloride ion did not interfere with the retention time of the fluoride. (3) The percentage coefficient of variation for analysis of precision, including repeatability and intermediate precision, is less than 2.0%. (4) Accuracy of method is within the range of 98%-102%. (5) The range of linearity is from 10 to 400 μg/ml, with the correlation coefficient (R(2)) always being above 0.9985. (6) The data of method robustness are within acceptance criteria. (7) The limit of detection and limit of quantification are 0.0678 and 0.20 μg/ml, respectively. All of the analysis results demonstrate that this method is highly sensitive, convenient, specific and suitable for quantification of NaF over a wide linear range. Therefore, the method can be successfully performed for routine analysis of fluoride content in [(18)F]NaF radiopharmaceuticals and reduce the time required for analysis.
(18)F-标记的氟化钠([(18)F]NaF)是一种有用的骨成像剂,已被证明比(99m)Tc 标记的亚甲基二膦酸盐在检测各种恶性肿瘤的硬化和溶骨性病变方面更准确。为了分析 [(18)F]NaF 放射性药物中的 NaF 含量和放射化学纯度,已经开发了一种可靠的阴离子交换 HPLC 方法,该方法配备了抑制电导率和放射性检测器。用于氟化物分析的方法使用 Hamilton 阴离子交换柱中 NaF 的等度洗脱,流动相由 7.5 mM 碳酸钠和 0.018 mM 硫氰酸钾组成。流速为 1.0 ml/min。该方法已根据几个参数进行了验证,包括系统适用性、专属性、精密度、准确度、线性、稳健性、检测限和定量限。结果如下:(1)系统适用性包括拖尾因子、理论板数和分辨率,分别为 1.192534、2729.6594 和 16.7415。(2)对于专属性,溶剂峰和氯离子不会干扰氟化物的保留时间。(3)精密度分析的百分比变异系数,包括重复性和中间精密度,小于 2.0%。(4)方法的准确度在 98%-102%范围内。(5)线性范围为 10-400 μg/ml,相关系数(R(2))始终大于 0.9985。(6)稳健性数据在可接受标准范围内。(7)检测限和定量限分别为 0.0678 和 0.20 μg/ml。所有分析结果表明,该方法具有高灵敏度、方便、专属性和适用于 [(18)F]NaF 放射性药物中 NaF 的宽线性范围定量。因此,该方法可成功用于 [(18)F]NaF 放射性药物中氟化物含量的常规分析,并减少分析所需的时间。